首頁 > 美迪醫訊 > 核磁共振成像:腦白質損傷?還是腫瘤復發? |
核磁共振成像:腦白質損傷?還是腫瘤復發? 【?2004-12-02 發布?】 美迪醫訊
根據一項最新研究發現:用于治療兩種類型大腦腫瘤(小腦幕上原始神經外胚瘤與成神經管細胞瘤)的大劑量化療與放療,能夠導致大腦白質在核磁共振成像檢查(magnetic resonance imaging,MRI)的時候上產生腫瘤樣的改變。 該研究由來自St. Jude兒科研究醫院( St. Jude Children’s Research Hospital,Memphis,TN,USA)研究人員完成。該研究報道說:這種損傷被稱為大腦白質損傷(white matter lesions,WMLs),會被誤認為腫瘤復發,從而促使醫生采用更加激進的方式(實際上是不必要的)治療患者,即使用更大劑量的化療和放療。 St. Jude醫院神經腫瘤科主任,該研究項目的主要作者Amar Gajjar醫學博士在文章中寫道:“放療與大劑量化療是一種我們希望盡可能保守地使用的治療方法。這個新發現給廣大臨床醫生提供了一個極其重要的警告,否則他們會將大腦白質損傷誤認是實際存在需要進一步治療的腫瘤。”該文章發表在2004年11月15日的《臨床腫瘤學期刊》上(the Journal of Clinical Oncology)。 腦白質損傷經常發生于手術后接受放療和大劑量化療的成神經管細胞瘤或者小腦幕上原始神經外胚瘤患者。這項研究也是第一次在兒童腦腫瘤患者中評估大腦白質的這種變化對智力的影響。特別是這項研究發現:出現腦白質損傷與神經認知、或者智力、功能的下降有關。 這篇文章的主要作者之一,St. Jude醫院血液科-腫瘤科的Maryam Fouladi醫學博士說:“對絕大多數兒童患者而言,接受治療后進行核磁共振掃描所發現的病變是腦白質損傷而不是癌癥。醫生可以反復使用核磁共振掃描來隨訪這些最初的病變,以確定腦白質損傷是否消失。如果確實消失了,那就不是癌癥也就無需治療。但是即使這些病變是暫時的,有些出現這種病變的兒童卻發展成永久的神經系統病變,例如吞咽困難?!?/FONT> 該項研究涉及了127例腦癌患者,在接受治療后隨訪了13個月。在這期間,患者中有22例由于治療而出現了腦白質損傷。在檢測到損傷后23.5個月內有16例患者(73%)腦白質損傷消失。有2例患者腦白質損傷分別持續了19個月和31個月。其它2例患者盡管仍然存在腦白質損傷,但是仍然再次形成了腫瘤。其余患者的腦白質損傷導致了組織破壞,出現腦白質損傷的患者的智商測驗和數字計算能力顯著降低。 研究者總結說:小腦幕上原始神經外胚瘤與成神經管細胞瘤的患者接受放療和大劑量化療后,腦白質損傷通常短期存在,并不產生癥狀。但是,腦白質損傷能夠與腫瘤復發的早期階段發生混淆,從而使得醫生很難準確判斷腫瘤是否復發。 MRI May Show Brain Lesions as Tumors The study, conducted by researchers from St. Jude Children’s Research Hospital (Memphis, TN,USA; www.stjude.org), report that this damage, called white matter lesions (WMLs), can be mistaken for recurrent tumors, prompting physicians to treat the patient aggressively--and unnecessarily--with more chemotherapy and radiation. “Irradiation and high-dose chemotherapy are treatments we want to use as sparingly as possible. This new information represents an important caution sign for physicians who otherwise might assume that WMLs are actually tumors that need further treatment,?said Amar Gajjar, M.D., director of neuro-oncology at St. Jude and senior author of the study, published in the November 15, 2004, issue of the Journal of Clinical Oncology. WMLs often occur in patients with medulloblastoma or PNET who have been treated with radiation and high-dose chemotherapy following surgery. This research is also the first to observe the effect of these changes in white matter on intellectual outcome in children with brain tumors. Particularly, the study discovered the presence of WMLs is linked with a decline in neurocognitive, or intellectual, function. “In the vast majority of children, the changes seen on MRI scans after treatment are WMLs and not cancer. Physicians can follow up these initial findings with repeat MRI scans to determine whether the WMLs disappear. If they do disappear, then it wasn’t cancer and didn’t require treatment. But even though these changes tend to be only temporary, some children with these changes tends to develop permanent neurologic problems, such as difficulty swallowing,?said Maryam Fouladi, M.D., from the department of hematology-oncology at St. Jude and lead author of the report. The study was comprised of 127 patients who were followed for up to 13 months after the initial treatment for brain cancer. During the time, 22 of these patients developed WMLs following the treatment. The WMLs disappeared in 16 patients (73%) within 23.5 months after being detected. In two patients the WMLs remained after 19 and 31 months, respectively. Two other patients developed tumors again while still showing evidence of WMLs. In the remaining patients, the WMLs led to tissue breakdown, and patients with WMLs experienced a significant decrease in estimated IQ and math scores. The investigators concluded that in patients with medulloblastomas or PNET who had been treated with irradiation and high-dose radiation, WMLs are typically short-lived and do not cause symptoms. WMLs, however, can mimic the early stages of tumor recurrence, and therefore make it hard for physicians to effectively diagnose tumor recurrence. 本文關鍵字:
核磁共振成像,腦白質損傷,腦腫瘤
《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢
更多關于 核磁共振成像,腦白質損傷,腦腫瘤 的新聞《上海醫療器械批發》產品推薦
|
合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
把美迪網放進收藏夾 把美迪醫療網介紹給我的朋友 給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303 美迪醫療網業務咨詢 互聯網藥品信息服務許可證:(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8 公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號 營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |